RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      사람백혈구항원 DR4-DQ4인 전격성 제1형 당뇨병 1예 = A Case of Fulminant Type 1 Diabetes Mellitus with Human Leukocyte Antigen DR4-DQ4

      한글로보기

      https://www.riss.kr/link?id=A104732871

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The clinical characteristics of fulminant type 1 diabetes are abrupt onset of disease, very short (<1 week) duration of diabetic symptoms,ketoacidosis at diagnosis, negativity for islet-related autoantibodies, virtually no C-peptide secretion (fast...

      The clinical characteristics of fulminant type 1 diabetes are abrupt onset of disease, very short (<1 week) duration of diabetic symptoms,ketoacidosis at diagnosis, negativity for islet-related autoantibodies, virtually no C-peptide secretion (fasting plasma C-peptide <0.3 ng/mL), a near normal hemoglobin A1c (HbA1c) level and an elevated serum pancreatic enzyme level. The pathogenesis has not yet been clarified, however the involvement of both genetic background and viral infections has been suggested. We reported a case of fulminant type 1 diabetes. A 37-year-old woman was admitted with stuporous consciousness to our hospital. Four days prior to the admission, she was hospitalized with the diagnosis of acute pancreatitis in another hospital, and at that time her glucose level was 79 mg/dL. Three days after the hospitalization, her state of consciousness became stuporous and she was transferred to our hospital. The laboratory results were as follows: pH 6.94, glucose 1,602 mg/dL, and HbA1c 5.5%. She was negative for islet-related autoantibodies and viral antibodies. HLA haplotypes were DRB1*04:05/*04:06, DQB1*03:02/*04:01 which might be a considerable risk allele for fulminant type 1 diabetes. She was diagnosed with fulminant type 1 diabetes, and has been treated with multiple component insulin regimens.

      더보기

      참고문헌 (Reference)

      1 Shimada A, "T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes" 25 : 635-636, 2002

      2 Imagawa A, "Pathogenesis of fulminant type 1 diabetes" 3 : 169-177, 2006

      3 Bottazzo GF, "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies" 2 : 1279-1283, 1974

      4 Imagawa A, "Fulminant type 1 diabetes: a nationwide survey in Japan" 26 : 2345-2352, 2003

      5 Zheng C, "Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese" 27 : 70-78, 2011

      6 Imagawa A, "Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus" 48 : 294-300, 2005

      7 Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation" 15 : 539-553, 1998

      8 Imagawa A, "A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence" 32 : 539-543, 2000

      9 Imagawa A, "A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies" 342 : 301-307, 2000

      10 Tanaka S, "A novel subtype of type 1 diabetes mellitus" 342 : 1835-1837, 2000

      1 Shimada A, "T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes" 25 : 635-636, 2002

      2 Imagawa A, "Pathogenesis of fulminant type 1 diabetes" 3 : 169-177, 2006

      3 Bottazzo GF, "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies" 2 : 1279-1283, 1974

      4 Imagawa A, "Fulminant type 1 diabetes: a nationwide survey in Japan" 26 : 2345-2352, 2003

      5 Zheng C, "Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese" 27 : 70-78, 2011

      6 Imagawa A, "Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus" 48 : 294-300, 2005

      7 Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation" 15 : 539-553, 1998

      8 Imagawa A, "A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence" 32 : 539-543, 2000

      9 Imagawa A, "A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies" 342 : 301-307, 2000

      10 Tanaka S, "A novel subtype of type 1 diabetes mellitus" 342 : 1835-1837, 2000

      11 Shimada A, "A case of fulminant type 1 diabetes with strong evidence of autoimmunity" 25 : 1482-1483, 2002

      12 Miura Y, "A case of fulminant type 1 diabetes with graves’ disease" 25 : 1894-1895, 2002

      13 Sakaue S, "A case of fulminant type 1 diabetes with elevated rheumatoid factor and the temporal presence of thyroid-stimulating hormone receptor antibody" 25 : 935-936, 2002

      14 Akatsuka H, "A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody" 84 : e50-e52, 2009

      15 Sano H, "A case of fulminant type 1 diabetes mellitus after influenza B infection" 79 : e8-e9, 2008

      16 Kwon JY, "A case of fulminant type 1 diabetes mellitus after hepatitis A infection" 10 : 118-122, 2009

      17 Goto A, "A case of fulminant type 1 diabetes associated with significant elevation of mumps titers" 55 : 561-564, 2008

      18 김덕룡, "A Korean patient with fulminant autoantibody-negative type 1 diabetes" AMER DIABETES ASSOC 27 : 3023-3024, 2004

      19 Taniyama M, "A Filipino patient with fulminant type 1 diabetes" 27 : 842-843, 2004

      20 김민선, "A Case of Fulminant Type 1 Diabetes Mellitus with Peripheral Neuropathy in a Korean Child" 대한소아내분비학회 14 (14): 82-84, 2009

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-12-16 학술지명변경 한글명 : 대한내분비학회지 -> Endocrinology and Metabolism
      외국어명 : Endocrinology and Metabolism -> 미등록
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-06-28 학술지명변경 외국어명 : Journal of Korean Endocrin Society -> Endocrinology and Metabolism KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-06-05 학회명변경 영문명 : The Korean Society Of Endocrinology -> Korean Endocrin Society KCI등재
      2007-06-01 학술지명변경 외국어명 : Journal of Korean Society of Endocrinology -> Journal of Korean Endocrin Society KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.26
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.508 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼